MindBio Completes AI Impairment Screening Kiosk, Targets Pilot This Year

MindBio Therapeutics Corp. has completed manufacturing a kiosk designed to identify potential drug or alcohol impairment by analyzing a person's voice, according to a press release, and is targeting an initial commercial pilot later this year to evaluate the technology in real-world settings. The kiosk builds on a prototype developed in June. Software integration, system testing and validation remain underway, with the company comparing its predictive models against breath-alcohol and oral-fluid tests. MindBio said its alcohol prediction model draws on more than 50 million data points. The company is targeting mining, aviation, construction, heavy transportation and law enforcement, aiming to make screening faster and less intrusive while reducing administrative costs and disruptions. The proposed pilot would help assess performance outside controlled settings and compare results with established testing methods. For operators, the launch is part of a broader trend: self-service kiosks are steadily expanding from transactions into health and safety screening, following eye-exam kiosks, hearing-test terminals and fatigue-detection pilots. Workplaces with safety-sensitive roles are becoming a viable placement category for unattended hardware, provided the accuracy claims hold up under real-world validation. Source: Kiosk Marketplace — https://www.kioskmarketplace.com/news/mindbio-completes-ai-impairment-screening-kiosk-targets-pilot-this-year/